0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

A Possible Oxazepam Abstinence Syndrome

Julian W. Selig Jr., MD
JAMA. 1966;198(8):951-952. doi:10.1001/jama.1966.03110210201057.
Text Size: A A A
Published online

OXAZEPAM (Serax) is a relatively new therapeutic agent. It is a 3-hydroxybenzodiazepin described as providing versatility and flexibility in control of common emotional disturbances, especially for the relief of anxiety. It is recommended that, when excessive dosage is continued for weeks or months, dosage should be reduced gradually rather than stopped abruptly. Sudden discontinuance of doses which are in excess of the recommended dose may result in epileptiform seizures. In the investigational work, a withdrawal psychosis was never observed.

In studies with chlordiazepoxide hydrochloride, a related benzodiazepin compound, Hollister et al1 have reported withdrawal symptoms in psychotic patients who were abruptly switched to placebo. Ten of 11 patients abruptly switched to placebo after several months of high daily doses (300 to 600 mg) experienced new symptoms and signs. Two patients had seizures at seven and eight days.

Hollister et al2 in one study evaluating diazepam (another related compound)

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();